Oravig Related Published Studies
Well-designed clinical trials related to Oravig (Miconazole)
Multicenter, double-blind, parallel group study investigating the non-inferiority
of efficacy and safety of a 2% miconazole nitrate shampoo in comparison with a 2%
ketoconazole shampoo in the treatment of seborrhoeic dermatitis of the scalp. [2014]
Multicenter, double-blind, parallel group study investigating the non-inferiority
of efficacy and safety of a 2% miconazole nitrate shampoo in comparison with a 2%
ketoconazole shampoo in the treatment of seborrhoeic dermatitis of the scalp. [2014]
Efficacy and tolerability of sertaconazole nitrate 2% cream vs. miconazole in patients with cutaneous dermatophytosis. [2011.05]
Miconazole oral gel increases exposure to oral oxycodone by inhibition of CYP2D6 and CYP3A4. [2011.03]
Randomized, comparative, double-blind, double-dummy, multicenter trial of miconazole buccal tablet and clotrimazole troches for the treatment of oropharyngeal candidiasis: study of miconazole Lauriad(R) efficacy and safety (SMiLES). [2010.07]
Antimicrobial central venous catheters in oncology: efficacy of a rifampicin-miconazole-releasing catheter. [2010.04]
Randomized, comparative, double-blind, double-dummy, multicenter trial of
miconazole buccal tablet and clotrimazole troches for the treatment of
oropharyngeal candidiasis: study of miconazole Lauriad® efficacy and safety
(SMiLES). [2010]
Sertaconazole 2% cream vs. miconazole 2% cream for cutaneous mycoses: a double-blind clinical trial. [2009.12]
In vitro and in vivo evaluation of a potentiated miconazole aural solution in chronic Malassezia otitis externa in dogs. [2009.10]
Oral voriconazole and miconazole oral gel produce comparable effects on the pharmacokinetics and pharmacodynamics of etoricoxib. [2009.01]
Comparison of the efficacy and safety of miconazole 50-mg mucoadhesive buccal tablets with miconazole 500-mg gel in the treatment of oropharyngeal candidiasis: a prospective, randomized, single-blind, multicenter, comparative, phase III trial in patients treated with radiotherapy for head and neck cancer. [2008.01.01]
Miconazole as adjuvant therapy for oral lichen planus: a double-blind randomized controlled trial. [2007.06]
Well-designed clinical trials possibly related to Oravig (Miconazole)
Effectiveness of microwave disinfection of complete dentures on the treatment of Candida-related denture stomatitis. [2008.11]
Is topical antimycotic treatment useful as adjuvant therapy for flexural atopic dermatitis: randomized, double-blind, controlled trial using one side of the elbow or knee as a control. [2008.02]
Other research related to Oravig (Miconazole)
Randomized Trial of Periodic Presumptive Treatment With High-Dose Intravaginal
Metronidazole and Miconazole to Prevent Vaginal Infections in HIV-negative Women. [2015]
Miconazole mucoadhesive tablet for oropharyngeal candidiasis. [2011.01]
Efficacy and tolerability of sertaconazole nitrate 2% cream vs. miconazole in
patients with cutaneous dermatophytosis. [2011]
Systemic uptake of miconazole during vaginal suppository use and effect on CYP1A2 and CYP3A4 associated enzyme activities in women. [2010.12]
In vitro profiling of pramiconazole and in vivo evaluation in Microsporum canis dermatitis and Candida albicans vaginitis laboratory models. [2010.11]
Hyperprothrombinemia as a result of a possible warfarin and intravaginal miconazole interaction. [2010.10]
Antifungal activity of miconazole against recent Candida strains. [2010.09]
Efficacy and tolerability of sertaconazole nitrate 2% cream vs. miconazole in patients with cutaneous dermatophytosis. [2009.11.18]
L(9) orthogonal design assisted formulation and evaluation of chitosan-based buccoadhesive films of miconazole nitrate. [2009.07]
Preparation and evaluation of miconazole nitrate-loaded solid lipid nanoparticles for topical delivery. [2009]
The use of rifampicin-miconazole-impregnated catheters reduces the incidence of femoral and jugular catheter-related bacteremia. [2008.11.01]
[Clinical effect and safety of miconazole nitrate 1200 mg in treating vulvovaginal candidiasis] [2008.10]
Efficacy and tolerance of metronidazole and miconazole nitrate in treatment of vaginitis. [2008.09]
Novelties in the multifaceted miconazole effects on skin disorders. [2008.08]
Miconazole revisited: new evidence of antifungal efficacy from laboratory and clinical trials. [2008.06]
[Colonization of Candida species and efficacy of miconazole gel in overdenture wearers] [2008.04]
Reduction of fluconazole susceptibility of Candida albicans in APECED patients due to long-term use of ketoconazole and miconazole. [2008]
Suction clearance and 2% topical miconazole versus the same combination with acidic drops in the treatment of otomycosis. [2007.07]
The effect of ambulation on vaginal distribution of miconazole nitrate (1200 mg). [2007.06]
Absorption and efficacy of miconazole nitrate 0.25% ointment in infants with diaper dermatitis. [2007.05]
Physical and chemical stability of miconazole liposomes prepared by supercritical aerosol solvent extraction system (ASES) process. [2007]
Other possibly related research studies
Effects of antifungal drugs and delivery vehicles on morphology and proliferation of equine corneal keratocytes in vitro. [2010.08]
Effectiveness of different central venous catheters for catheter-related infections: a network meta-analysis. [2010.09]
Use of itraconazole and either lime sulphur or Malaseb Concentrate Rinse to treat shelter cats naturally infected with Microsporum canis: an open field trial. [2010.06.29]
Antimicrobial activity of topical skin pharmaceuticals - an in vitro study. [2010.05]
Nosocomial transmission of Candida pelliculosa fungemia in a pediatric intensive care unit and review of the literature. [2010.01]
Otomycosis: Diagnosis and treatment. [2010.03.04]
Antifungal drug resistance of oral fungi. [2010.02]
Use of antifungal agents for oral candidiasis: results of a national survey. [2010.02]
In vitro activities of azole antifungal agents against Propionibacterium acnes isolated from patients with acne vulgaris. [2010.01]
[Guidelines for diagnosis and treatment of mucocutaneous candidiasis] [2009]
Prophylactic oral/topical non-absorbed antifungal agents to prevent invasive fungal infection in very low birth weight infants. [2009.10.07]
In vitro susceptibility patterns of Aspergillus and Fusarium species isolated from equine ulcerative keratomycosis cases in the midwestern and southern United States with inclusion of the new antifungal agent voriconazole. [2009.09]
Fungal keratitis in a gopher tortoise (Gopherus polyphemus). [2009.09]
Trichophyton tonsurans-Ringworm in an NICU. [2009.09]
[Young man with intermittent dysphagia] [2009.08.26]
Susceptibility profile of vaginal isolates of Candida albicans prior to and following fluconazole introduction - impact of two decades. [2009.06.26]
Superficial distribution and identification of antifungal/antimicrobial agents on a modified tissue conditioner by SEM-EDS microanalysis: a preliminary study. [2009.10]
[Evaluation of susceptibility to antifungal agents of fungal strains isolated from pregnant women with diabetes and healthy pregnant women] [2009.04]
Enalapril treatment alters the contribution of epoxyeicosatrienoic acids but not gap junctions to endothelium-derived hyperpolarizing factor activity in mesenteric arteries of spontaneously hypertensive rats. [2009.08]
Giant inguinoscrotal hernia. [2009.04]
Contact sensitization in venous eczema: preliminary results of patch testing with Indian standard series and topical medicaments. [2009.03]
Sertaconazole: a review of its use in the management of superficial mycoses in dermatology and gynaecology. [2009]
Evidence-based veterinary dermatology: a systematic review of interventions for Malassezia dermatitis in dogs. [2009.02]
Angular cheilitis occurring during orthodontic treatment: a case series. [2008.12]
Dermatoscopy in the diagnosis of tinea nigra. [2008.08.15]
Successful resolution of dermatophyte mycetoma following terbinafine treatment in two cats. [2008.12]
Aspergillus mastoiditis, presenting with unexplained progressive otalgia, in an immunocompetent (older) patient. [2009.10]
Topical fenticonazole in dermatology and gynaecology: current role in therapy. [2008]
The advantages of topical combination therapy in the treatment of inflammatory dermatomycoses. [2008.09]
Isolated frontal sinusitis due to Pseudallescheria boydii. [2008.07]
Efficacy of Brazilian propolis gel for the management of denture stomatitis: a pilot study. [2008.11]
Three isolations of Chaetomium globosum from erythematous epilation of canine skin. [2008.08]
Reconstructed interfollicular feline epidermis as a model for the screening of antifungal drugs against Microsporum canis. [2008.06]
[Case of sycosis candidiasis on the upper lip] [2008]
Assessment of the treatment protocol described in the guidelines for Trichophyton tonsurans infection. [2008]
Medical interventions for fungal keratitis. [2008.01.23]
Inhibition of the transient receptor potential cation channel TRPM2 by 2-aminoethoxydiphenyl borate (2-APB). [2008.03]
Microsporum canis in a neonatal intensive care unit patient. [2008.02]
In vitro susceptibility patterns of fungi associated with keratomycosis in horses of the northeastern United States: 68 cases (1987-2006). [2007.10.01]
[Treatment of fungal infections of upper respiratory tract and ear] [2007]
Keratitis caused by a rare fungus, Malassezia restricta. [2007.07]
Tongue pain: burning mouth syndrome vs Candida- associated lesion. [2007.07]
Deep fungal dermatitis in three inland bearded dragons (Pogona vitticeps) caused by the Chrysosporium anamorph of Nannizziopsis vriesii. [2007.06]
Lecythophora hoffmannii isolated from a case of canine osteomyelitis in Japan. [2007.05]
[How I treat....A stoutness-associated intertrigo] [2007.02]
Estimation of intragastric solubility of drugs: in what medium? [2007.05]
Azole therapy of clinical and experimental coccidioidomycosis. [2007.09]
Coccidioidomycosis: changing perceptions and creating opportunities for its control. [2007.09]
Molecular typing and antifungal susceptibility of Trichophyton rubrum isolates from patients with onychomycosis pre- and post-treatment. [2007.05]
Contact dermatitis to a canine anti-dandruff shampoo. [2007.02]
Use of isolated infected spores to determine the sporocidal efficacy of two commercial antifungal rinses against Microsporum canis. [2007.02]
Metabolism of adrenic acid to vasodilatory 1alpha,1beta-dihomo-epoxyeicosatrienoic acids by bovine coronary arteries. [2007.05]
Inflammatory papillary hyperplasia of the palate: treatment with carbon dioxide laser, followed by restoration with an implant-supported prosthesis. [2007.12]
Post-traumatic fungal endophthalmitis--a prospective study. [2008.01]
Comparison of two shampoos for the treatment of canine Malassezia dermatitis: a randomised controlled trial. [2011.11]
Boric acid for recurrent vulvovaginal candidiasis: the clinical evidence. [2011.08]
Contact dermatitis caused by dimethylfumarate in Argentina. [2011.07]
Mortierella wolfii keratomycosis in a horse. [2011.07]
Liquid chromatographic and spectrophotometric determination of diflucortolone valerate and isoconazole nitrate in creams. [2011.01]
Enhancement of drug solubility and absorption by copolymers of 2-methacryloyloxyethyl phosphorylcholine and n-butyl methacrylate. [2011]
Rechargeable infection-responsive antifungal denture materials. [2010.12]
[Pustules from the cow barn]. [2010.11]
[Results of antifungal susceptibility testing of Candida species and trends of antifungal use in Niigata university medical and dental hospital]. [2010.07]
Use of itraconazole and either lime sulphur or Malaseb Concentrate Rinse (R) to treat shelter cats naturally infected with Microsporum canis: an open field trial. [2011.02]
Prevalence and treatment management of oropharyngeal candidiasis in cancer patients: results of the French CANDIDOSCOPE study. [2011.06.01]
Design and development of solid lipid nanoparticles for topical delivery of an anti-fungal agent. [2010.08]
|